Let AI watch the worldβs key changes for you unkAI
unkAI continuously tracks the public intelligence and global changes you care about, and only alerts you when noteworthy new developments emerge. Subscribe for free by email β no repeated interruptions, no missed key changes.
Health
44 items Β· Recommended
Innovative drug prices and market dynamics after the implementation of China's medical insurance catalog
Focus on the admission progress, price adjustment, sales growth of newly added innovative drugs and their impact on corporate performance after the 2026 update of China's medical insurance catalog.
NMPA approval results of China's Class 1 innovative drugs
Follow up the approval process of Class 1 chemical innovative drugs entering the final stage of comprehensive review, focus on CDE review conclusions, NMPA administrative approval results and approval time.
Implementation progress of China's 15th Five-Year Plan for the revitalization and development of traditional Chinese medicine
Follow up the policy implementation of the "15th Five-Year Plan for the Revitalization and Development of Traditional Chinese Medicine", and focus on the progress of inheritance, innovation, modernization promotion and internationalization of traditional Chinese medicine.
Progress of new drug approvals by China NMPA in the second half of 2026
Follow up on the review progress and approval results of 8 blockbuster drugs rushing to market, and observe changes in indication coverage and market competition landscape.
Changes and dynamics of global respiratory virus activity
Combined with WHO weekly updates, track changes in the prevalence range, positive rate and variant strains of respiratory viruses such as influenza, COVID-19 and RSV around the world.
Approval nodes of the world's first innovative drug for narcolepsy in the United States and Japan
Follow up on the review progress and approval results of this globally first-approved selective orexin-2 receptor agonist in China, in the United States and Japan.
Progress in the research and development of multi-targeted innovative drugs in China
Track R&D breakthroughs, clinical trial progress, approval nodes and listing dynamics of drugs with multi-targeted systemic regulatory functions.
Progress of Phase III clinical trial of the innovative traditional Chinese medicine Qingshen Tongluo Granules
Follow up on the promotion rhythm of multi-center clinical trials, patient enrollment progress, and clinical trial data results, and pay attention to the final data unblinding and subsequent marketing application nodes.